Furthermore, the training interventions showed a greater effect in the reduction of fibroblast‐growth factor 21 (FGF21) and interleukin‐6 (IL‐6) in patients with CAD and T2D than in patients with CAD alone. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.